Voie d'immunisation et séquence d'administration de l ... - TEL
Voie d'immunisation et séquence d'administration de l ... - TEL Voie d'immunisation et séquence d'administration de l ... - TEL
tel-00827710, version 1 - 29 May 2013 Fig.3. Flow cytometry based-HLA typing (Human). PBMCs are prepared as usual, then incubated with either isotype or anti-HLA antibody of interest titrated to the optimal concentration. Histograms represent data obtained from one HLA-A2 positive (left) and one HLA-A2 negative (right) blood donors. 230
tel-00827710, version 1 - 29 May 2013 Fig.4. Representative example of single and double multimer staining. PBMCs from one healthy donor were stained with Influenza A-Matrix158-66 MHCI multimer labeled either in PE (left), APC (middle), or both (right). Plots are gated into global CD8 + population using the gating strategy described in Section 3.5-Figure 5A. Page 231 of 256
- Page 179 and 180: tel-00827710, version 1 - 29 May 20
- Page 181 and 182: tel-00827710, version 1 - 29 May 20
- Page 183 and 184: tel-00827710, version 1 - 29 May 20
- Page 185 and 186: tel-00827710, version 1 - 29 May 20
- Page 187 and 188: tel-00827710, version 1 - 29 May 20
- Page 189 and 190: tel-00827710, version 1 - 29 May 20
- Page 191 and 192: tel-00827710, version 1 - 29 May 20
- Page 193 and 194: tel-00827710, version 1 - 29 May 20
- Page 195 and 196: tel-00827710, version 1 - 29 May 20
- Page 197 and 198: tel-00827710, version 1 - 29 May 20
- Page 199 and 200: tel-00827710, version 1 - 29 May 20
- Page 201 and 202: tel-00827710, version 1 - 29 May 20
- Page 203 and 204: tel-00827710, version 1 - 29 May 20
- Page 205 and 206: tel-00827710, version 1 - 29 May 20
- Page 207 and 208: tel-00827710, version 1 - 29 May 20
- Page 209 and 210: tel-00827710, version 1 - 29 May 20
- Page 211 and 212: tel-00827710, version 1 - 29 May 20
- Page 213 and 214: tel-00827710, version 1 - 29 May 20
- Page 215 and 216: tel-00827710, version 1 - 29 May 20
- Page 217 and 218: tel-00827710, version 1 - 29 May 20
- Page 219 and 220: tel-00827710, version 1 - 29 May 20
- Page 221 and 222: tel-00827710, version 1 - 29 May 20
- Page 223 and 224: tel-00827710, version 1 - 29 May 20
- Page 225 and 226: tel-00827710, version 1 - 29 May 20
- Page 227 and 228: tel-00827710, version 1 - 29 May 20
- Page 229: tel-00827710, version 1 - 29 May 20
- Page 233 and 234: tel-00827710, version 1 - 29 May 20
- Page 235 and 236: tel-00827710, version 1 - 29 May 20
- Page 237 and 238: tel-00827710, version 1 - 29 May 20
- Page 239 and 240: tel-00827710, version 1 - 29 May 20
- Page 241 and 242: tel-00827710, version 1 - 29 May 20
- Page 243 and 244: tel-00827710, version 1 - 29 May 20
- Page 245 and 246: tel-00827710, version 1 - 29 May 20
- Page 247 and 248: tel-00827710, version 1 - 29 May 20
- Page 249 and 250: tel-00827710, version 1 - 29 May 20
- Page 251 and 252: tel-00827710, version 1 - 29 May 20
- Page 253 and 254: tel-00827710, version 1 - 29 May 20
- Page 255 and 256: tel-00827710, version 1 - 29 May 20
tel-00827710, version 1 - 29 May 2013<br />
Fig.4. Representative example of single and double multimer staining. PBMCs from one healthy donor were<br />
stained with Influenza A-Matrix158-66 MHCI multimer labeled either in PE (left), APC (middle), or both<br />
(right). Plots are gated into global CD8 + population using the gating strategy <strong>de</strong>scribed in Section 3.5-Figure<br />
5A.<br />
Page 231 of 256